SPILLO stands out for its ability to identify target and off-target proteins for any molecule—whether in development or on the market—on a proteome-wide scale, offering strategic advantages across all stages of drug R&D.
Powered by exclusive, experimentally validated physics-based technology.
Products, services, technology
Unbiased analyses of the structural proteome of Homo sapiens and other key organisms to identify Targets and Off-Targets for: - predicting/elucidating Therapeutic and/or Adverse Effects, including rare ones, at the biomolecular level; - identifying opportunities for Drug Rescue/Repurposing; - etc.
- https://www.spillo.ch
- +41 76 626 83 00
- Send an email
- Alessandro Di Domizio
